Wrana, F.; Dötzer, K.; Prüfer, M.; Werner, J.; Mayer, B.
High Dual Expression of the Biomarkers CD44v6/α2β1 and CD44v6/PD-L1 Indicate Early Recurrence after Colorectal Hepatic Metastasectomy. Cancers 2022, 14, 1939.
https://doi.org/10.3390/cancers14081939
AMA Style
Wrana F, Dötzer K, Prüfer M, Werner J, Mayer B.
High Dual Expression of the Biomarkers CD44v6/α2β1 and CD44v6/PD-L1 Indicate Early Recurrence after Colorectal Hepatic Metastasectomy. Cancers. 2022; 14(8):1939.
https://doi.org/10.3390/cancers14081939
Chicago/Turabian Style
Wrana, Friederike, Katharina Dötzer, Martin Prüfer, Jens Werner, and Barbara Mayer.
2022. "High Dual Expression of the Biomarkers CD44v6/α2β1 and CD44v6/PD-L1 Indicate Early Recurrence after Colorectal Hepatic Metastasectomy" Cancers 14, no. 8: 1939.
https://doi.org/10.3390/cancers14081939
APA Style
Wrana, F., Dötzer, K., Prüfer, M., Werner, J., & Mayer, B.
(2022). High Dual Expression of the Biomarkers CD44v6/α2β1 and CD44v6/PD-L1 Indicate Early Recurrence after Colorectal Hepatic Metastasectomy. Cancers, 14(8), 1939.
https://doi.org/10.3390/cancers14081939